News releases

HungaroTrial contributed to EU authorization of a new COVID-19 medication, Regkirona (CT-P59)

HungaroTrial is proud to announce the completion of enrolment in a global Phase III. Breast Cancer trial

HungaroTrial is featured in a recent article in the leading news media in South Korea

We are announcing the launch of our new video about HungaroTrial’s Medical Device Services

HungaroTrial has received approval for a new COVID-19 phase II. clinical trial in Romania

HungaroTrial CRO has been selected for the full service coverage of a Phase I. vaccination clinical trial

Proud to Announce: We are ISO 9001 Certified

We are announcing the launch of our new Medical Device website

HungaroTrial is happy to announce their collaboration in the Largest Single Phase III Breast Cancer Clinical Trial in its History

CEO of HungaroTrial CRO has received Scientist of Medicines Development postgraduate certification at Semmelweis University

Announcing the opening of our new office in Prague, Czech Republic

We are happy to announce the successful accomplishment of a device study in acute myocardial infarct

Announce of opening HT Research UK

We are happy to announce the successful accomplishment of a Phase2 Infectology study

Winning Excellence Award from the Cra Academija in Serbia

Announce of opening new office in Sofia , Bulgaria

HungaroTrial opens up new office in Belgrade, Serbia

HungaroTrial has been selected as the full service provider for a PhaseII. multicenter, multinational clinical trial

We are happy to announce that we have successfully concluded a Phase III Anal Fissure study

HungaroTrial Featured in Recent Interview on

HungaroTrial launches informative four-part Clinical Trials Webinar Series addressing Eastern Europe

HungaroTrial extends its reach to two additional countries – market-leading CRO unveils brand new image

Come friend us on Facebook

Follow HungaroTrial on Twitter!

HungaroTrial transforms into closed corporation